Correlation between the Warburg effect and progression of triple-negative breast cancer

13Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

76051Citations
N/AReaders
Get full text

Why do cancers have high aerobic glycolysis?

4094Citations
N/AReaders
Get full text

The metabolism of tumors in the body

3261Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy

47Citations
N/AReaders
Get full text

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway

21Citations
N/AReaders
Get full text

The Significance of Microenvironmental and Circulating Lactate in Breast Cancer

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liu, S., Li, Y., Yuan, M., Song, Q., & Liu, M. (2023, January 27). Correlation between the Warburg effect and progression of triple-negative breast cancer. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.1060495

Readers over time

‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

53%

Lecturer / Post doc 4

24%

Researcher 3

18%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 10

59%

Agricultural and Biological Sciences 3

18%

Engineering 2

12%

Chemistry 2

12%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 30

Save time finding and organizing research with Mendeley

Sign up for free
0